moxifloxacin has been researched along with vitamin k 1 in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (vitamin k 1) | Trials (vitamin k 1) | Recent Studies (post-2010) (vitamin k 1) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,699 | 131 | 410 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berube, C; Lee, R; Wen, A | 1 |
1 review(s) available for moxifloxacin and vitamin k 1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for moxifloxacin and vitamin k 1
| Article | Year |
|---|---|
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
Topics: Acetaminophen; Adjuvants, Immunologic; Aged, 80 and over; Analgesics, Non-Narcotic; Anti-Infective Agents; Anticoagulants; Antifibrinolytic Agents; Aza Compounds; BCG Vaccine; Drug Interactions; Fluoroquinolones; Humans; International Normalized Ratio; Male; Moxifloxacin; Quinolines; Urinary Bladder Neoplasms; Vitamin K 1; Warfarin | 2011 |